ToleroMune Ragweed

BIOLOGICAL4 trials

Sponsors

Circassia Limited

Conditions

AllergyRagweed AllergyRhinoconjunctivitis

Phase 2

Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

CompletedNCT00878774

Circassia LimitedAllergy

Start: 2009-04-30End: 2009-11-30Target: 50Updated: 2010-11-10

ToleroMune Ragweed Exposure Chamber Study

CompletedNCT01198613

Circassia LimitedRagweed Allergy

Start: 2010-09-30End: 2011-08-31Target: 275Updated: 2011-10-07

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

CompletedNCT01361412

Circassia LimitedRagweed Allergy

Start: 2011-03-31End: 2011-09-30Target: 20Updated: 2011-10-07

Unknown Phase

ToleroMune Ragweed Follow up Study

CompletedNCT01448603

Circassia LimitedRagweed Allergy, Rhinoconjunctivitis

Start: 2011-10-31End: 2012-03-31Updated: 2012-05-17